Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan Window Therapy for High-Risk Neuroblastoma
NCT00186849Phase 2Completed
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Oct 1997
- Primary completion
- Apr 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of topotecan in neuroblastoma, sponsored by St. Jude Children's Research Hospital. Primary endpoint: Response Rate to Upfront Window at 5 years. Started Oct 1997; status: completed.
02
Drugs
topotecan
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00186849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186849.